Drug abuse can be defined as the dependency, addiction, overuse of drugs such as opioids, nicotine, alcohol, cigarettes, and heroin, which are most commonly used by majority of population around the globe. There are several drugs such as Disulfiram, Acamprosate, Naltrexone, and Nicotine Replacement Therapy, which are used for treatment of addiction and dependency on these drugs.
Grab Sample of this Report at: @
Market Dynamics
Frequent product launches, approvals, and robust pipeline of novel products are expected to be the major driver for growth of the global drug abuse treatment market over forecast period. For instance, in April 2018, Lil\’ Drug Store Products Inc. launched its Nicotac brand nicotine gum in the market. Lil\’ Drug Store Products Inc. has launched its Nicotac in two nicotine strengths (2MG and 4MG nicotine polarcrilex). Furthermore, the increasing prevalence of drug abuse is expected to increase the demand for its treatment drugs which in turn is expected to fuel global drug abuse treatment market growth. For instance, according to the data published by World Health Organization (WHO) in 2018, around 7 million people die worldwide annually due to tobacco abuse.
Key features of the study:
This report provides in-depth analysis of drug abuse treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global drug abuse treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil\’ Drug Store Products Inc., Indivior Plc., Dr. Reddy\’s Laboratories, Teva Pharmaceutical Industries Ltd., British American Tobacco plc. and others
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the drug abuse treatment market
Detailed Segmentation:
Global Drug Abuse Treatment Market, By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
Global Drug Abuse Treatment Market, By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Buprenorphine
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
Global Drug Abuse Treatment Market, By Distribution Channel:
Hospital
Retail Pharmacies
Online Pharmacies
Global Drug Abuse Treatment Market, By Geography:
North America Drug Abuse Treatment Market
By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Methadone
Buprenorphine
Nicotine Addiction Treatment
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Europe Drug Abuse Treatment Market
By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Methadone
Buprenorphine
Nicotine Addiction Treatment
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific Drug Abuse Treatment Market
By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Methadone
Buprenorphine
Nicotine Addiction Treatment
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America Drug Abuse Treatment Market
By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Methadone
Buprenorphine
Nicotine Addiction Treatment
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East Drug Abuse Treatment Market
By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Methadone
Buprenorphine
Nicotine Addiction Treatment
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa Drug Abuse Treatment Market
By Abuse Type :
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
By Drug Type:
Disulfiram
Acamprosate
Naltrexone
Methadone
Buprenorphine
Nicotine Addiction Treatment
Nicotine Replacement Treatment
Nicotine Patch
Nicotine Gum
Nicotine Lozenge
Nicotine Spray
Nicotine Inhaler
Non-Nicotine Medication
Bupropion
Varenicline
Others
By Distribution Channel
Hospital
Retail Pharmacies
Online Pharmacies
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Cipla Limited*
Company Overview
Product Portfolio
Recent Developments
Financial Performance
Key Strategies
Glenmark Pharmaceuticals
Pfizer Inc.
Mylan N.V.
Odyssey Pharmaceuticals Inc.
Lil\’ Drug Store Products Inc.
Indivior Plc.
Dr. Reddy\’s Laboratories
Teva Pharmaceutical Industries Ltd.
British American Tobacco plc.
Get Exclusive Discount at: @
“*” marked represents similar segmentation in other categories in the respective section.
Industry Forecast Research 